Paradigm Biocapital Advisors LP Ocular Therapeutix, Inc Transaction History
Paradigm Biocapital Advisors LP
- $3.1 Billion
- Q3 2025
A detailed history of Paradigm Biocapital Advisors LP transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Paradigm Biocapital Advisors LP holds 3,497,307 shares of OCUL stock, worth $39.8 Million. This represents 1.32% of its overall portfolio holdings.
Number of Shares
3,497,307
Previous 3,420,340
2.25%
Holding current value
$39.8 Million
Previous $31.7 Million
28.81%
% of portfolio
1.32%
Previous 1.48%
Shares
3 transactions
Others Institutions Holding OCUL
# of Institutions
236Shares Held
157MCall Options Held
1.24MPut Options Held
423K-
Vr Adviser, LLC New York, NY13.2MShares$150 Million23.37% of portfolio
-
Summer Road LLC West Palm Beach, FL12.6MShares$143 Million98.91% of portfolio
-
Deep Track Capital, LP Greenwich, CT11.9MShares$136 Million4.4% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$131 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.3MShares$117 Million1.64% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $875M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...